Parkervision Inc: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Mar 16, 2015 and accepted by EDGAR at Mar 16, 2015, 20:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $0 | us-gaap:Revenues |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $0 | us-gaap:CostOfServices |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $0 | us-gaap:GrossProfit |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $0 | us-gaap:GrossProfit |
| Research and development | 12 months2014-01-01 to 2014-12-31 | $8.5m | us-gaap:ResearchAndDevelopmentExpense |
| Interest expense | 12 months2014-01-01 to 2014-12-31 | $6.9k | us-gaap:InterestExpense |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | −$5.5m | us-gaap:NetIncomeLoss |
| Net income | 12 months2014-01-01 to 2014-12-31 | −$23.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | −$0.06 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | −$0.24 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | −$18.5m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 12 months2014-01-01 to 2014-12-31 | $401.3k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-12-31 | $218.9k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $12.1m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $20.7m | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $2.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-31 | $2.1m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-12-31 | $18.6m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000914139-15-000006. Last ingested by Listed: Nov 11, 2026, 01:56 ET. Listed shows no prices and gives no investment advice.